AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 109 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $89,000 | -23.3% | 143,088 | +3.6% | 0.03% | -26.8% |
| Q3 2019 | $116,000 | +28.9% | 138,085 | +2.6% | 0.04% | +32.3% |
| Q2 2019 | $90,000 | -20.4% | 134,585 | -2.8% | 0.03% | -22.5% |
| Q1 2019 | $113,000 | +151.1% | 138,505 | +390.5% | 0.04% | +122.2% |
| Q4 2018 | $45,000 | -8.2% | 28,235 | +88.2% | 0.02% | +5.9% |
| Q3 2018 | $49,000 | – | 15,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VI & Co. LLC | 675,242 | $1,884,000 | 100.00% |
| Prosight Management, LP | 1,057,690 | $2,951,000 | 2.17% |
| NEA Management Company, LLC | 16,362,694 | $45,652,000 | 1.89% |
| EMORY UNIVERSITY | 602,883 | $1,682,000 | 1.44% |
| New Leaf Venture Partners, L.L.C. | 964,520 | $2,691,000 | 1.26% |
| RA Capital Management | 5,062,759 | $14,125,000 | 1.18% |
| Avoro Capital Advisors LLC | 4,006,893 | $11,179,000 | 0.72% |
| 683 Capital Management, LLC | 2,500,000 | $6,975,000 | 0.59% |
| X-Square Capital, LLC | 199,345 | $557,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,300,000 | $3,627,000 | 0.43% |